Marker composition for prediction of prognosis and anticancer drug susceptibility in cancer patients

Item Number: 581
Industry: Diagnostic
Category: Oncology
Development Stage: Early Stage
Organisation Type: Private Corporation
Country: South Korea
Patent: Korea, EU
Business Opportunity: Out-Licensing, Technology Transfer, Collaboration R&D


The technology relates to a single nucleotide polymorphism (SNP) marker for predicting the sensitivity to an anticancer targeted drug, a polynucleotide containing the same, and a method for predicting the sensitivity to a specific anticancer targeted drug. 

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it